Illumina, Inc. (ILMN)
197.00
-3.66
(-1.82%)
USD |
NASDAQ |
Nov 20, 10:10
Illumina Cash from Operations (Quarterly) : 419.00M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 419.00M |
| June 30, 2026 | 201.00M |
| March 31, 2026 | 289.00M |
| December 31, 2025 | 321.00M |
| September 30, 2025 | 284.00M |
| June 30, 2025 | 234.00M |
| March 31, 2025 | 240.00M |
| December 31, 2024 | 364.00M |
| September 30, 2024 | 316.00M |
| June 30, 2024 | 80.00M |
| March 31, 2024 | 77.00M |
| December 31, 2023 | 223.00M |
| September 30, 2023 | 139.00M |
| June 30, 2023 | 105.00M |
| March 31, 2023 | 10.00M |
| December 31, 2022 | 147.00M |
| September 30, 2022 | -52.00M |
| June 30, 2022 | 125.00M |
| March 31, 2022 | 172.00M |
| December 31, 2021 | 282.00M |
| September 30, 2021 | -272.00M |
| June 30, 2021 | 253.00M |
| March 31, 2021 | 282.00M |
| December 31, 2020 | 406.00M |
| September 30, 2020 | 153.00M |
| Date | Value |
|---|---|
| June 30, 2020 | 240.00M |
| March 31, 2020 | 281.00M |
| December 31, 2019 | 443.00M |
| September 30, 2019 | 267.00M |
| June 30, 2019 | 143.00M |
| March 31, 2019 | 198.00M |
| December 31, 2018 | 300.00M |
| September 30, 2018 | 292.00M |
| June 30, 2018 | 295.00M |
| March 31, 2018 | 255.00M |
| December 31, 2017 | 294.00M |
| September 30, 2017 | 235.00M |
| June 30, 2017 | 178.00M |
| March 31, 2017 | 168.00M |
| December 31, 2016 | 280.15M |
| September 30, 2016 | 150.30M |
| June 30, 2016 | 217.05M |
| March 31, 2016 | 39.74M |
| December 31, 2015 | 240.38M |
| September 30, 2015 | 180.99M |
| June 30, 2015 | 171.44M |
| March 31, 2015 | 66.78M |
| December 31, 2014 | 140.55M |
| September 30, 2014 | 145.60M |
| June 30, 2014 | 178.03M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 519.00M |
| Thermo Fisher Scientific, Inc. | 2.55B |
| Bio-Rad Laboratories, Inc. | 96.40M |
| Danaher Corp. | 1.886B |
| QIAGEN NV | 145.62M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 50.00M |
| Cash from Financing (Quarterly) | -222.00M |
| Free Cash Flow | 637.00M |
| Free Cash Flow Per Share (Quarterly) | 2.461 |
| Free Cash Flow to Equity (Quarterly) | 593.00M |
| Free Cash Flow to Firm (Quarterly) | 399.00M |
| Free Cash Flow Yield | 2.13% |